{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Brooksville",
      "state": "FL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "64188",
      "recalling_firm": "TG United, Inc.",
      "address_1": "16275 Aviation Loop Dr",
      "address_2": "N/A",
      "postal_code": "34604-6805",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "FL, MS, SC, LA  and TX",
      "recall_number": "D-525-2013",
      "product_description": "BroveX PSE DM, Antihistamine, Cough Suppressant,   Decongestant, 100 count bottle, OTC, Manufactured for: Pernix Therapeutics, Gonzales, LA 70737    NDC 58605-441-01",
      "product_quantity": "16,836 bottles - 100-count.",
      "reason_for_recall": "CGMP Deviations: Products are underdosed or have an incorrect dosage regime.",
      "recall_initiation_date": "20130130",
      "center_classification_date": "20130604",
      "termination_date": "20160930",
      "report_date": "20130612",
      "code_info": "Lot# 11A002  Exp. 12/12; Lot# 11A003  Exp. 12/12; Lot # 11A004  Exp. 12/12; Lot# 11A005 Exp. 12/12; Lot# 11L003 Exp. 10/13."
    }
  ]
}